Search details
1.
Outcomes from treatment of metastatic renal-cell carcinoma following failure of first-line anti-VEGF/VEGFR therapy: real-life evidence on the change of the treatment paradigm.
Anticancer Drugs
; 34(3): 413-421, 2023 03 01.
Article
in English
| MEDLINE | ID: mdl-36730619
2.
Why Metformin Should Not Be Used as an Oxidative Phosphorylation Inhibitor in Cancer Patients.
Chemotherapy
; 68(4): 185-189, 2023.
Article
in English
| MEDLINE | ID: mdl-37343530
3.
Ursolic Acid against Prostate and Urogenital Cancers: A Review of In Vitro and In Vivo Studies.
Int J Mol Sci
; 24(8)2023 Apr 18.
Article
in English
| MEDLINE | ID: mdl-37108576
4.
Orphan receptors in prostate cancer.
Prostate
; 82(10): 1016-1024, 2022 06.
Article
in English
| MEDLINE | ID: mdl-35538397
5.
ß-Blocker Use and Risk of Recurrence in Patients with Early Breast Cancer.
Chemotherapy
; 60(5-6): 288-9, 2014.
Article
in English
| MEDLINE | ID: mdl-25998892
6.
Multiple primary malignancies: a report of two cases.
Chin J Cancer Res
; 26(2): 215-8, 2014 Apr.
Article
in English
| MEDLINE | ID: mdl-24826064
7.
Novel insights into voltage-gated ion channels: Translational breakthroughs in medical oncology.
Channels (Austin)
; 18(1): 2297605, 2024 12.
Article
in English
| MEDLINE | ID: mdl-38154047
8.
Protease-Activated Receptors (PARs): Biology and Therapeutic Potential in Perioperative Stroke.
Transl Stroke Res
; 2024 Feb 07.
Article
in English
| MEDLINE | ID: mdl-38326662
9.
Niclosamide in prostate cancer: An inhibitor of AR-V7, a mitochondrial uncoupler, or more?
Cancer Treat Res Commun
; 35: 100685, 2023.
Article
in English
| MEDLINE | ID: mdl-36706514
10.
The Role οf Ion Channels in the Development and Progression of Prostate Cancer.
Mol Diagn Ther
; 27(2): 227-242, 2023 03.
Article
in English
| MEDLINE | ID: mdl-36600143
11.
Current Status of Tivozanib in the Treatment of Patients With Advanced Renal Cell Carcinoma.
Cureus
; 15(3): e35675, 2023 Mar.
Article
in English
| MEDLINE | ID: mdl-37012938
12.
The Relation of Calculated Plasma Volume Status to Sublingual Microcirculatory Blood Flow and Organ Injury.
J Pers Med
; 13(7)2023 Jun 30.
Article
in English
| MEDLINE | ID: mdl-37511698
13.
Effects of Vasopressin Receptor Agonists during the Resuscitation of Hemorrhagic Shock: A Systematic Review and Meta-Analysis of Experimental and Clinical Studies.
J Pers Med
; 13(7)2023 Jul 16.
Article
in English
| MEDLINE | ID: mdl-37511756
14.
Characterization of prostate cancer adrenal metastases: dependence upon androgen receptor signaling and steroid hormones.
Prostate Cancer Prostatic Dis
; 26(4): 751-758, 2023 Dec.
Article
in English
| MEDLINE | ID: mdl-36100698
15.
Is the glucocorticoid receptor a key player in prostate cancer?: A literature review.
Medicine (Baltimore)
; 101(29): e29716, 2022 Jul 22.
Article
in English
| MEDLINE | ID: mdl-35866830
16.
Androgen receptor signaling-mitochondrial DNA-oxidative phosphorylation: A critical triangle in early prostate cancer.
Curr Urol
; 16(4): 207-212, 2022 Dec.
Article
in English
| MEDLINE | ID: mdl-36714229
17.
Patterns of indolence in prostate cancer (Review).
Exp Ther Med
; 23(5): 351, 2022 May.
Article
in English
| MEDLINE | ID: mdl-35493432
18.
Burnout Syndrome among Doctors in Greek Oncology Departments.
Iran J Psychiatry
; 17(2): 162-176, 2022 Apr.
Article
in English
| MEDLINE | ID: mdl-36262756
19.
Potential Ophthalmological Side Effects Induced by Anti-Neoplastic Regimens for the Treatment of Genitourinary Cancers: A Review.
Cureus
; 14(7): e27266, 2022 Jul.
Article
in English
| MEDLINE | ID: mdl-36039252
20.
Risk for Arterial Thromboembolic Events (ATEs) in Patients with Advanced Urinary Tract Cancer (aUTC) Treated with First-Line Chemotherapy: Single-Center, Observational Study.
Curr Oncol
; 29(9): 6077-6090, 2022 08 24.
Article
in English
| MEDLINE | ID: mdl-36135047